Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Meticore appears to be a direct-to-consumer dietary supplement brand centered on a commercial weight-management product sold online. Publicly available information indicates it markets a metabolism and fat-burning supplement positioned around raising low core body temperature, but there is little evidence of a conventional biotech or pharmaceutical R&D pipeline. The business is better characterized as a nutraceutical or wellness brand than a drug developer. Available sources suggest operations tied to McHenry, Illinois and an e-commerce model rather than regulated therapeutic development. There is no clear evidence that Meticore is a public company, acquired company, or a life sciences platform company with clinical-stage assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Meticore.